VTRO (Vitro Biopharma) Research & Development: $0.16 Mil (TTM As of Oct. 2022)


What is Vitro Biopharma Research & Development?

Vitro Biopharma VTRO Research & Development is $0.16 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Vitro Biopharma's Research & Development for the three months ended in Oct. 2022 was $0.16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2022 was $0.16 Mil.

Vitro Biopharma  (AMEX:VTRO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Vitro Biopharma Research & Development Related Terms

Vitro Biopharma Research & Development Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Research & Development Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.15 0.12 0.12 0.16

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.15 0.12 0.12 0.16

Vitro Biopharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.16 Mil mean?
Vitro Biopharma (VTRO) has a Research & Development of $0.16 Mil as of Oct. 2022. Research and development expense is the total cost for research and development activities. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's Research & Development too high?
Vitro Biopharma's current Research & Development is $0.16 Mil.
How does Vitro Biopharma's Research & Development compare to ?
Vitro Biopharma's Research & Development of $0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current Research & Development is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Research & Development of $0.16 Mil. The current Research & Development is $0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Research & Development is $0.16 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.